SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 27.25+4.2%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Edscharp who wrote (9344)3/23/1999 12:40:00 PM
From: aknahow  Read Replies (2) of 17367
 
Ed, without the <g>, I am not 100% sure you are kidding. Any extension of the trial was assumed by some posters here and on Yahooh to be a negative event that would be punished by the market. Some, thought an extension meant Neuprex did not work. Well the extension has occurred and the market appeared to understand that it was not a negative event. But, the key was the assurance that the trial is close to conclusion. If the trial continues and continues that becomes a negative as there is no news to support the stock, cash drain continues and marketing even if the drug is successful is pushed even farther into the future. I think you knew all this and were just illustrating the dangers of too much of a good thing!

P.S. Ed, I am 99.9% certain you were kidding. The above post is for Robert K, to make sure he understands you were.<g>
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext